Multaq - Investigational Agent for the Treatment of Cardiac Arrhythmia


Dronedarone is a new Class III antiarrhythmic drug under development by Sanofi-Aventis.

  • Dronedarone - Antiarrhythmic drug
  • Sanofi-Synthelabo's Ambarès manufacturing facility
  • A granulation operator
  • Ambarès manufacturing facility
  • Monitoring substance dissolution
  • Monitoring tablet production
  • Vials of tablets


| 1 | 2 | 3 | 4 | 5 | 6 | 7 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development